{"slug":"state-page","tag":"state-page","variants":["state-page"],"description":"No description yet","count":1,"kinds":{"cancer":1},"related":[{"slug":"head-and-neck","tag":"head-and-neck","shared":1},{"slug":"subtype-page","tag":"subtype-page","shared":1}],"records":[{"id":"recurrent-metastatic-hnscc","kind":"cancer","name":"Recurrent or metastatic head and neck squamous cell carcinoma","route":"/cancers/recurrent-metastatic-hnscc/","tldr":"When head and neck cancer comes back where it cannot be removed, or spreads elsewhere, it is treated to extend life rather than cure: pembrolizumab, alone or with chemotherapy, is the first choice, cetuximab-based regimens and cheap oral chemotherapy are alternatives, and antibodies that hit two targets at once are in late-stage trials."}]}